N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide

C26H27FN4O2S — CID 31834339

IUPACN-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide
SMILESCC(=O)N(c1ccccc1)c1nc(/C=C/C(=O)N2CCCN(Cc3ccc(F)cc3)CC2)cs1
InChIInChI=1S/C26H27FN4O2S/c1-20(32)31(24-6-3-2-4-7-24)26-28-23(19-34-26)12-13-25(33)30-15-5-14-29(16-17-30)18-21-8-10-22(27)11-9-21/h2-4,6-13,19H,5,14-18H2,1H3/b13-12+
InChIKeyVKVIWIWRMSASLE-OUKQBFOZSA-N
MW478.59 g/mol
LogP4.71
Rot. Bonds6

About N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide

N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide (PubChem CID 31834339) has the molecular formula C26H27FN4O2S and a molecular weight of 478.59 g/mol. Its IUPAC name is N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide.

Molecular Properties

Compound NameN-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide
PubChem CID31834339
Molecular FormulaC26H27FN4O2S
Molecular Weight478.59 g/mol
Exact Mass478.18
IUPAC NameN-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide
SMILESCC(=O)N(c1ccccc1)c1nc(/C=C/C(=O)N2CCCN(Cc3ccc(F)cc3)CC2)cs1
InChIInChI=1S/C26H27FN4O2S/c1-20(32)31(24-6-3-2-4-7-24)26-28-23(19-34-26)12-13-25(33)30-15-5-14-29(16-17-30)18-21-8-10-22(27)11-9-21/h2-4,6-13,19H,5,14-18H2,1H3/b13-12+
InChIKeyVKVIWIWRMSASLE-OUKQBFOZSA-N
XLogP4.71
TPSA56.75 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500478.59
LogP ≤ 54.71
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide?
The IUPAC name of N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide (CID 31834339) is N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide.
What is the SMILES notation for N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide?
The canonical SMILES for N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide is CC(=O)N(c1ccccc1)c1nc(/C=C/C(=O)N2CCCN(Cc3ccc(F)cc3)CC2)cs1.
What is the InChIKey of N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide?
The InChIKey is VKVIWIWRMSASLE-OUKQBFOZSA-N. The full InChI is InChI=1S/C26H27FN4O2S/c1-20(32)31(24-6-3-2-4-7-24)26-28-23(19-34-26)12-13-25(33)30-15-5-14-29(16-17-30)18-21-8-10-22(27)11-9-21/h2-4,6-13,19H,5,14-18H2,1H3/b13-12+.
What are the key properties of N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide?
N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide has a molecular weight of 478.59 g/mol, XLogP of 4.71, 6 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[(E)-3-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]-3-oxoprop-1-enyl]-1,3-thiazol-2-yl]-N-phenylacetamide is sourced from PubChem (CID 31834339), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).